chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got the vaccine, got very dizzy immediately after and kept her for 30  minutes and gave her water.  Then driving home she started feeling itchy, and could feel little hives in each ear.  She was then very lethargic that night and all the next day Sunday, and then first thing Monday morning was covered with a large hives and a rash.  She was covered from one end of her body to the other and into her joints where she was not able to bend her joints.  She tried to use cortisone, but that made it worse.  Also tried Benadryl lotion and Calamine lotion, which also did not help.  She then went to the doctor and he prescribed steroids.  She has had pain as if somebody was sticking needles in her.  In the past 2 days her lips are numb and swelled, and on the right cheek plus her two eyes there is a big swollen area and her eyes are burning.  Now her entire body is peeling as if she had a bad sunburn.   Now her blood sugar due to the steroids is from 250-475.  The site of the vaccine itself was ok.
Patient said 30 minutes after vaccine administration he experienced fever, chills, achiness, tiredness, and has been sick for several days and has had to call off work.
Bleeding at injection site; Feeling sick; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site hemorrhage in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of malaise (On 25th January 2023, received 1st dose and experienced feeling sick, refer case US2023AMR049488).   On 01-APR-2023, the patient received the 2nd dose of Shingrix (intramuscular). On 01-APR-2023, immediately after receiving Shingrix, the patient experienced injection site hemorrhage (Verbatim: Bleeding at injection site) and feeling unwell (Verbatim: Feeling sick). Rechallenge with Shingrix was positive. The outcome of the injection site hemorrhage and feeling unwell were resolved.   It was unknown if the reporter considered the injection site hemorrhage and feeling unwell to be related to Shingrix.     It was unknown if the company considered the injection site hemorrhage and feeling unwell to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR049488   Additional Information: GSK Receipt date: 03-APR-2023. Patient stated that he had his second dose of Shingrix and felt sick again and that there was bleeding at the injection site immediately after receiving the dose. The reporter consented to follow up.; Sender's Comments:  US-GSK-US2023AMR049488:Same reporter
She developed an itchy rash on her hands and feet that goes up her legs and arms. They are red flat small bumps. The rash extends to her palms and the balls of her feet.
Vaccine that administered beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient's age was reported as 24 years and 2 months. No concomitant medication was provided. It was reported that vaccine was administered beyond use date to the patients. There was no adverse reaction noted or reported regarding these administrations. Vaccine code- 80777-0273-99. No treatment medication was provided.
Pt was vaccinated with Moderna on 12-21-2020 apporx 1:00PM. states had slight muscle soreness about 24 hours after injection that resolved the next day. On 12-28-2020 started having soreness in axillary area. By next day, 12-29-2020 states had fever that never got higher than 100.6, itching, muscle soreness, redness, swelling and hard to touch at injection site. States also started having a headache that is still having today (12-31-2020). Seen PCP on 12/29/2020 (APN) who RX Keflex 500mg x 7 days and Prednisone 20mg BID x 10 days. PCP did rapid COVID test which was negative. Pt came to HD on 12-30-2020 for me to see her arm. Left arm was red and "puffy". States sore to touch. F/U call today reveals
Started on 4/9/21 (1 day post vaccination) with lower back pain and impaired ability to walk. Progressed to numbness and pain in the lower extremities.  Unable to walk.  Presented to the Emergency Room on 4/10/21 and was admitted.  MRI showed inflammation in spinal cord.  Treated with IVIG and IV steroids.  Diagnosed as myelitis.  Remains hospitalized and scheduled for spinal tap 4/12/21
malaise; headache; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 21 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 21 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization.  The following information was reported: MALAISE (non-serious) with onset 22Dec2021, outcome "unknown", described as "malaise"; HEADACHE (non-serious) with onset 22Dec2021, outcome "unknown", described as "headache".  The lot number for bnt162b2 was not provided and will be requested during follow up.
After the second shoe on 3/9/2021, and over the next few days I became increasing inactive and found that I was unable to breath deeply and had tightness in my chest area. On 3/20/2021 I went to the Emergency Room and  Health Center.
Mom called to report pt has seizure following last immun @ approx 2AM morning following shot, pt screamed loudly then shook & cried; Reportedly was dressed heavily & felt hot; No temp taken;
The next day after second dose she developed a blistering rash on left chest from mid line to midline back - Photo shown - Quality of pain + appearance consistent with shingles but getting 2nd dose the 19th.
Initial pain at the injection site  - which resolved within 24 hours. After 3 weeks, mild rash on the stomach area. Very  Itchy.   The rash is there for 2 days. Taking Benadryl.  Not much reduction.
This spontaneous report was received from a medical assistant and refers to an unknown number of patients of unknown age and gender. The patients' concomitant medications, pertinent medical history and drug reactions or allergies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX injection, lot # m048200 with expiry date on 07-DEC-2018 (exact dose and route of administration were not reported). The doses were administered together with sterile diluent (STERILE DILUENT) and were exposed to the temperature between 6 and 14 degrees Fahrenheit for 14 hours. There was no previous temperature excursion. Digital data logger was not involved. No adverse effects were reported. Product quality complaint was not involved. Additional information has been requested.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-OCT-2015, the patient, who was on therapy with an unspecified dose of methotrexate (manufacturer unknown) was inadvertently administered a dose of VARIVAX (Merck) instead of ZOSTAVAX, (dose, frequency, and route of administration not reported). No adverse effects reported. No product quality complaint (PQC) was involved. No further information provided. Additional information has been requested.
Within 15-minutes of vaccination, the patient reported arm swelling around injection site. EMS monitored the patient's condition on-site.
No adverse reaction occurred. Vaccine was out of the temperature range for approximately 2 months and then was administered yesterday not knowing was one of the out of temperature  range vaccines.
Redness, swelling of left deltoid.  Area is 3" long & approx 2 1/2" wide.  Area is warm to touch.  Started 6-10-10 & is worse - more swollen & red on 6-11-10.  Mother will make MD appt. with Dr.  Area also itchy.
Fever for 5 days, Chills, body aches, migraine like headaches in left eye, fatigue, weakness, nerve pain in left arm up to my neck, electric shock type of pain.
Pregnancy history: G2P1001. Patient had the Pfizer COVID vaccine on 8/6/21 at 33 3/7 weeks gestation (EDD 9/21/21). Presented 8/15/21 at 34 5/7 weeks gestation with preterm labor. CBC with differential found to have significant abnormalities. Twins were delivered via C-section. Twin A birth weight 5lb 2.5oz and twin B birth weight 6lb 1.4oz. Oncology consulted and bone marrow biopsy diagnosed patient with AML. Induction chemotherapy with 7+3 given 8/17-8/23/21 with resulting pancytopenia necessitating daily blood/platelet transfusions. On 9/1/21, had a catastrophic intracranial hemorrhage and patient died on 9/2/21.
Left upper arm redness, tenderness, warm to touch. Onset 2 days post vaccination. Localized reaction on site where Varicella was administered.
Severe chills and lethargy on Monday - slept all day. Moderate chills and slight headache on right rear in the morning on Tuesday. A little lasting lethargy today.
Information has been received from a physician concerning a 70 year old female with no pre-existing allergies, birth defects or medical conditions who on 27-MAY-2007 was vaccinated in the left arm with a first dose of Zostavax (Oka/Merck).  On 31-MAY-2007 the patient experienced right facial pain.  The patient had a negative CT and MRI.  There was no illness at the time of the vaccination.  There were no adverse events following prior vaccination.  Unspecified medical attention was sought through a neurologist.  The patient was better after taking gabapentin (Neurontin).  The outcome was reported as recovering.  There was no product quality complaint.  Additional information has been requested.
symptoms of an autoimmune disease; This spontaneous case was reported by a patient family member or friend and describes the occurrence of AUTOIMMUNE DISORDER (symptoms of an autoimmune disease) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced AUTOIMMUNE DISORDER (symptoms of an autoimmune disease) (seriousness criterion medically significant). At the time of the report, AUTOIMMUNE DISORDER (symptoms of an autoimmune disease) outcome was unknown.            No concomitant medications were reported. Patient had been vaccinated multiple times and had been in and out of the hospital. Patient was showing symptoms of an autoimmune disease. Now that there was overwhelming evidence that vaccine was killing people and harming people. The reporter did not see why it would be a problem to get money through the court system. Treatment information was not provided.  Company comment:  This spontaneous case report concerns a female patient of unknown age, with no medical history provided, who experienced the unexpected serious (medically significant) event of autoimmune disorder. Reportedly, the patient had symptoms of an autoimmune disease. The event occurred on an unknown date after a dose of mRNA-1273.222 (bivalent vaccine, dose of the vaccine in vaccination schedule was not specified). As per information provided, the patient had been vaccinated multiple times and had been in and out of the hospital, however, no additional details were provided. No further information regarding final diagnosis, specific signs and symptoms, clinical course, laboratory investigations, diagnostic procedures and treatment medications was provided. Limited information precludes a meaningful medical assessment at this point. Case will be re-assessed upon receipt of additional information. The benefit-risk relationship of mRNA-1273.222 is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-707862, US-MODERNATX, INC.-MOD-2023-707867 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-707862:case for grandfather US-MODERNATX, INC.-MOD-2023-707867:case for mother
Inconsolable crying & high pitched cry approx 5 hrs p/recvd vax; mom states also had limpness; used only APAP gtts for temp; episode lasted approx 8 hrs;
Heart palpitations and high blood pressure -BP was out of control I waited for a couple of days to see if it goes away - on the four day of the symptoms I saw my doctor. The doctor January 13 - Increased dose on my BP medicine to lower the Blood pressure. Symptoms resolved right before 2nd dose. They went away about the 26th of January. Decreased to my normal dose, my BP medicine, when my blood pressure went down. I received the 2nd dose of vaccine January 30th.
Rash showed up on Sunday June 2nd. It gradually got bigger to the size of a salad plate, rash was on Rt. side from under breast to near umbilicus. It was slightly itchy.
A non-serious report of administration of expired FluMist has been received from a nurse concerning an eight-year-old female.  Neither medical history nor concomitant medications were provided.  The patient received FluMist on 13-Mar-2008.  The FluMist had expired on 10-Mar-2008.  The reporter stated that she received 100 doses of FluMist from the Vaccines For Children Program on 22-Feb-2008 and the vaccine expired on 10-Mar-2008.  The clinic did not realize the expiration date on the product and continued to give it from 11-Mar-2008 to 17-Mar-2008 to 26 patients.  The patient had no adverse events at the time the report was received, neither as of 18-Apr-2008 when the office was contacted for follow-up information.  The event was resolved.  It was not reported whether or not FluMist was re-administered.  The reporter provided no causality assessment for the event.  The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.  Follow-up information received 18-Apr-2008 and incorporated into the narrative: no adverse event occurred.  This case is linked to the following 25 other cases reported from the same reporter: MEDI-0006660; MEDI-0006661; MEDI-0006662; MEDI0006663; MEDI-0006664; MEDI-0006665; MEDI-0006666; MEDI-0006667; MEDI-0006668; MEDI-0006669; MEDI-0006670; MEDI-0006671; MEDI-0006672; MEDI-0006659; MEDI-0006674; MEDI-0006675; MEDI-0006676; MEDI-0006677; MEDI-0006678; MEDI-0006679; MEDI-0006680; MEDI-0006681; MEDI-0006682; MEDI-0006683; MEDI-0006684.
9/9/2022 2:32pm  Shingrix Vaccine administered 9/9/2022 5:30pm I was lying on bed, reading. Sudden unusual aching and pain appeared on bottoms of both feet, ankles, then spreading up to both knees. Rubbing them did not aleviate discomfort. Walking around a bit seemed to help, but this strange aching returned as soon as I was sitting or lying down. (This symptom is still ongoing, however, and now added 2 episodes of foot cramping and foot dystonia which began on 9/27/2022) Numbness + tingling ongoing since 9/9/2022 9/11/2022 Sudden overall body weakness, followed by quick, stabbing, "electrical shock" pains along distal edge of right hand, followed by left hand about an hour later, This symptom continued while sleeping for 3 nights, Hand issue has since subsided. 9/13/2022 Sharp pain R temple followed by deep bruising pain behind right eye. Painful to touch and when moving eyes. Aspirin helped. 9/15/2022 Sclera of R eye became blood red still very painful move or touch. 9/17/2022 12:00pm Office visit with APRN. Suggested that Shingrix vaccine was creating autoimmune reaction related to having Sjogrens. Prescribed Gabapentin for nerve pain, which I have NOT taken (I'm very afraid of any medications). 9/17/2022 2:12pm Office visit with Ophthalmologist. Indicated that this was autoimmune reaction to Shingrix vaccine because of Sjogrens. Prescribed Prednisolone ACE 1% Eye drops. This medication quickly helped R eye. 9/18/2022 Same pain/redness sequence of symptoms began in left eye. Used Prednisolone Eye Drops to resolve. 9/24/2022 Sudden onset of body weakness and trembling (?) Hand "electrical shocks" and severe surprise "diarrhea". Rest and lots of water helped. 9/28/2022 Contact Dr (my rheumatologist for Sjogrens) to let him know of these Shingrix/Sjogrens developments.
Developed area around injection site that became very red and warm on day 2. On day 3, redness had reduced some but it was swollen more (down to elbow) and still warm. She called her doctor, who prescribed BACTRIM DS as a precaution. Will follow up with patient in 2 days.
Had swelling in her neck to her back and into her arm (injection arm)./her whole arm was swollen; As per caller her whole arm was swollen and "rock hard" and could not move her arm; Had swelling in her neck to her back and into her arm (injection arm).; This is a spontaneous report from a contactable consumer reporting for herself.  A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) on 16Oct2019 at single dose in arm for immunisation . The patient medical history and concomitant medications were not reported. On an unspecified date in Oct2019, the patient had swelling in her neck to her back and into her arm (injection arm). Patient reported her whole arm was swollen and "rock hard" and could not move her arm. She remained in bed all day "lying on a heating pad". She called the doctor who told her to take ibuprofen. The final outcome of the events was unknown. Information on the batch number has been requested.
Naseau Lightheadedness Throat swelling Full body itchiness 50mg Benadryl administered within 10 min of shot which caused symptoms to stop progressing repeat dose of 50mg 3 hrs later symptoms decreasing by evening (10 hrs post injection) but still present.
Getting COVID-19 vaccine, left arm. Side effect of swollen lymph nodes and under arm pain and tenderness more than 7 days, continuous Left side only, semi-constricting.
The first shot was on 4/6/2021 and the second one was on 4/27/2021. About a week before I got Shot #2, I begin to experience a consistent scratchy throat with a persistent cough. Then my breathing begin to change and I started experiencing a type of sleep apnea, whereby I am demonstratively trying to breath. My partner found this so troubling that she recorded it on several occasions. I have gone to see my PCP twice. She recommended that I see both a pulmonologists and cardiologists. I had a low dose CT Scan of my chest, a pulmonary function test, and a stress test with echo. I have been taking copious amounts of cough syrup, cough drops, tea, lemon, honey. Nothing is helping. I am still having co
No adverse effects were reported; 13 unspecified patients were administered a dose of ROTATEQ / The shipment took 4 days to arrive (on a refrigerated vaccine that is only guaranteed with a one day delivery); shipment of ROTATEQ was supposed to be delivered on 10-MAY-2019, however, wasnot received until 13-MAY-2019; This spontaneous report was received from an office manager and an specified reporter from the Customer Resolution Team referring to 13 patients of unknown age and gender. The patients' concurrent conditions, past medical history, concomitant medications, and drug reactions or allergies were not reported.  On 10-MAY-2019, a shipment of vaccine, live, oral, pentavalent (ROTATEQ) was supposed to be delivered, however, it was not received until 13-MAY-2019 (Product distribution issue). Shipment was received late; it took 4 days to arrive (on a refrigerated vaccine that is only guaranteed with a one day delivery). On unspecified dates in 2019 since that day, the patients received improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot # R035367 and expiration date of 07-OCT-2020) (dose not reported), orally for prophylaxis. It was advised to not use the doses but by this time, 13 doses of the 25 pack were already administered. No data was available for the temperature or the time frame during the time the shipment was delayed. There were no previous temperature excursions and a data logger was not involved. No adverse effects were reported..  The outcome of product distribution issue and was resolved on 13-MAY-2019. The causality  was not provided..  This is a non-valid case due to lack of patients' identifiers.
lips swelling; This is a spontaneous report from a contactable consumer reported for herself.    A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), from lot number #EL9267on 14Feb2021 09:00 AM (at 58 year old) at single dose via unspecified route at the left arm, for COVID-19 immunization. Medical history included Anaphylactic reaction to the Capsaicin Family, thyroid and High Blood Pressure. Concomitant medications included levothyroxine sodium (SYNTHROID), lisinopril, verapamil and loratadine (CLARITIN). The patient was not pregnant. No COVID prior vaccination. The patient had not been tested for COVID since the vaccination. On 14Feb2021 09:15 AM the patient experienced lips swelling. The outcome of the event was unknown. The patient visited Emergency room for the event and treatment was received, steroid shot and prednisone for 5 days.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the unspecified number of patients were vaccinated with improperly stored (in temperature 34-35 unit unknown) unspecified doses of RECOMBIVAX HB lot # K023863, expiry date: 03-APR-2016 or lot # L009155, expiry date: 29-OCT-2016 or lot # L016959, expiry date: 12-MAR-2016 (dose, site and route of administration were not reported). This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a health professional concerning a 24 year old female who on 25-OCT-2007 was vaccinated IM with the first dose of GARDASIL vaccine (yeast) (lot # 657872/0515U). Concomitant therapy included Yazz-hormonal contraceptives (unspecified). About five minutes after vaccination the patient passed out. The patient came to and about 45-60 minutes later she passed out again. The patient urinated about 5 minutes before passed out for the second time. The physician took blood pressure and pulse each time the patient fainted. The first blood pressure read 119/75 pulse 52, second blood pressure taken while the patient was still lying down unconscious read 130/71 pulse 55, and the third time when patient came to and the blood pressure was 135/80 pulse 55. The patient had a fainting incident before, when she was 12 and she passed out at the dentist office when she received a shot inside her mouth. Medical attention was not sought. The patient was recovered. No product quality complaint was involved.